Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Aging (Albany NY) ; 16(9): 7870-7888, 2024 May 03.
Article in English | MEDLINE | ID: mdl-38709288

ABSTRACT

BMP9 has demonstrated significant osteogenic potential. In this study, we investigated the effect of Leptin on BMP9-induced osteogenic differentiation. Firstly, we found Leptin was decreased during BMP9-induced osteogenic differentiation and serum Leptin concentrations were increased in the ovariectomized (OVX) rats. Both in vitro and in vivo, exogenous expression of Leptin inhibited the process of osteogenic differentiation, whereas silencing Leptin enhanced. Exogenous Leptin could increase the malonylation of ß-catenin. However, BMP9 could increase the level of Sirt5 and subsequently decrease the malonylation of ß-catenin; the BMP9-induced osteogenic differentiation was inhibited by silencing Sirt5. These data suggested that Leptin can inhibit the BMP9-induced osteogenic differentiation, which may be mediated through reducing the activity of Wnt/ß-catenin signalling via down-regulating Sirt5 to increase the malonylation level of ß-catenin partly.


Subject(s)
Down-Regulation , Growth Differentiation Factor 2 , Leptin , Osteogenesis , Sirtuins , Wnt Signaling Pathway , beta Catenin , Animals , beta Catenin/metabolism , beta Catenin/genetics , Sirtuins/metabolism , Sirtuins/genetics , Female , Rats , Osteogenesis/drug effects , Leptin/metabolism , Leptin/pharmacology , Growth Differentiation Factor 2/metabolism , Wnt Signaling Pathway/drug effects , Ovariectomy , Cell Differentiation/drug effects , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...